Trial intelligence / Profile preview

Pain control in musculoskeletal chronic pain diseases with pregabalin, mirogabalin or duloxetine

jRCTs031190172Recruiting

Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Trial of pregabalin, mirogabalin and duloxetine in cervical spondylomyelopathy (CSM), Herniated Lumbar Disk, lumbar spinal stenosis (LSS) and 4 more (3 arms). Primary endpoint: Assessment of CNS activity. Started Jan 2020; status: recruiting.

02

Drugs

pregabalinmirogabalinduloxetine
03

Conditions

cervical spondylomyelopathy (CSM)Herniated Lumbar Disklumbar spinal stenosis (LSS)carpal tunnel syndrome (CTS)hip osteoarthritis

Beyond the preview

Go deeper on jRCTs031190172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031190172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call